Total Funding
80
60
Total FundingGrant raised
Growth Score
-11 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
103704
Galaxy Therapeutics provides neurovascular devices that treats cerebral aneurysms.
- Sam Zaidat: President and Chief Executive Officer
- Michael Alexander: Chief Medical OfficerPast Role: Cedars Sinai, Professor and Vice-Chairman
About the Company
Galaxy Therapeutics provides neurovascular devices that increase the rate of curing the disease and offer easy deployment, fluoroscopic visualization, and treatment for shallow or large aneurysms, enabling patients to avail improved medical treatment.
